AMTI Announces New CTO

AMTI is pleased to announce that Dr. Mary Beth Schmidt has joined the company as chief technology officer, effective April 4, 2016. Mary Beth has 23 years of research and development experience in the medical device industry, with a focus in orthopedics and biomaterials. Most recently, Mary Beth successfully ran Schmidt Biomedical, LLC, a medical device consulting business for over 12 years, serving clients ranging from Fortune 500 companies to small start-up enterprises. Prior to this, she spent more than 10 years within different business units at Johnson & Johnson, with technical and leadership responsibilities that included developing reduced wear polyethylene for total joint replacement components and evaluating alternative low wear bearing technologies using joint simulator testing. Working in the AMTI wear testing laboratory as a contractor, she regularly performed wear tests for emerging medical device companies. In addition, she provided hands-on training for simulator customers and valuable user feedback to AMTI.
 
Mary Beth received her Ph.D. and M.S. degrees in biomedical engineering from Rensselaer Polytechnic Institute and a B.S. degree in mechanical engineering from Lehigh University. Following graduate school, she managed a research laboratory at Columbia University studying mechano-chemical changes in articular cartilage due to osteoarthritis. Mary Beth is also a co-inventor on five U.S. patents.
 
Mary Beth brings her extensive and varied medical device experience to this leadership role at AMTI. With this significant addition, the company continues to expand and strengthen its commitment to advancing testing technology for the orthopedic industry.